1 Questions 2 Answers 0 Followers
Questions related from Abdurahman Alloghbi
We are conducting a systemic reveiw about secondary mutations and mechanisms of resistence in patients with EGFR+ non-small cell lung cancer who recieved TKIs therapy. We work remotely using...
13 February 2019 7,643 3 View